Cell and Gene Therapy Commercialization: Lessons Learned from a CEO
Sue Washer, MBA
Former President and CEO
Applied Genetics Technologies Corp.
Member, SEC Small Business Capital Formation Advisory Committee
Member, Board of Directors, BioFlorida
Cell and Gene Therapy Commercialization: Lessons Learned from a CEO
Date: April 28, 2026
Time: 2 p.m.
Room 3012, 2 Riverside Circle, Fralin Biomedical Research Institute at VTC
About this Seminar
Sue Washer is the former president and CEO of Applied Genetics Technologies Corp. (AGTC). During her more than 20 years there, she was prominently involved in the University of Florida and state of Florida start-up ecosystem. AGTC was a clinical-stage biotechnology company focused on developing Adeno-associated virus (AAV)-based gene therapies for rare, inherited retinal diseases. It was sold in 2022 to Syncona, which ultimately launched Beacon Therapeutics with the AGTC gene therapy assets. She brings a decade of experience in pharmaceutical management and research with Abbott Labs and Eli Lilly & Co., with an additional nine years of senior management experience with entrepreneurial firms. At AGTC, she secured private and public investments of more than $290 million, negotiated and closed two major collaborations with top biotech companies resulting in more than $150 million of cash in-flows, and led AGTC in efficiently completing critical scientific milestones. She is an appointed member of the Small Business Capital Formation Advisory Committee for the SEC, past associate vice president of the ECSGB Board of Bio, and currently serves as a director of BioFlorida. She earned her undergraduate degree in biochemistry from Michigan State University and her MBA from the University of Florida, where she was one of the first graduates from the Warrington College of Business Entrepreneurship program.
You May Also Be Interested In...
-
Home Item
Presenting Therapeutic Peptides Using Synthetic Polymers , homeNov. 20, 2026, 11:00 a.m. | Rachel A. Letteri, Ph.D., Associate Professor, Departments of Chemical Engineering, University of Virginia | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research
-
Home Item
Three Lessons About the Brain from the Neuroscience of Emotion , homeDec. 10, 2026, 5:30 p.m. (Reception at 5 p.m.) | Lisa Feldman Barrett, Ph.D., University Distinguished Professor, Northeastern University and Massachusetts General Hospital | Maury Strauss Distinguished Public Lecture
-
Home Item
The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , homeDec. 11, 2026, 11:00 a.m. | Paule V. Joseph, Ph.D., MBA, M.S., Senior Investigator, Lasker Clinical Research Scholar, NIH Distinguished Scholar, Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD; Co-Director, National Smell and Taste Center; Attending Nurse Practitioner, Division of Intramural Clinical and Biological Research; National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and Other Communication Disorders | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research
-
Home Item
Learning and Memory in the Infant Brain , homeJan. 29, 2026, 11:00 a.m. | Nicholas B. Turk-Browne, Ph.D., Susan Nolen-Hoeksema Professor of Psychology; Director, Wu Tsai Institute, Yale University | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Human Neuroscience Research
-
Home Item
How Sleep Shapes the Infant Brain , homeFeb. 12, 2027, 11:00 a.m. | Mark Blumberg, Ph.D., University of Iowa Distinguished Chair, Department Chair, Psychological & Brain Sciences, The University of Iowa | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Neurobiology Research
-
Home Item
The Science of Individuality: What Makes Us Who We Are? , homeFeb. 26, 2027, 11:00 a.m. | Terry Jernigan, Ph.D., Distinguished Professor of Cognitive Science, Psychiatry, and Radiology; Director, UCSD Center for Human Development, University of California, San Diego | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research